UBS O'Connor’s SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 SBXC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-88,226
Closed -$9.75K 618
2024
Q3
$9.75K Sell
88,226
-2,850
-3% -$369 ﹤0.01% 464
2024
Q2
$13.2K Hold
91,076
﹤0.01% 491
2024
Q1
$11.4K Hold
91,076
﹤0.01% 482
2023
Q4
$8.43K Buy
+91,076
New +$11.1K ﹤0.01% 461

UBS O'Connor's SBXC.WS Position: Q4 2024 in Review

UBS O'Connor sold out of SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (SBXC.WS) in Q4 2024, closing a stake of 88,226 shares — an estimated $9.75K sold.

UBS O'Connor first reported a position in SBXC.WS in Q4 2023 and held it in 4 quarters. The position peaked at $13.2K in Q2 2024. 1 fund tracked by Wall St. Rank holds SBXC.WS as of Q4 2024.

  • UBS O'Connor reported no remaining SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 88,226 SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2024, an estimated $9.75K.
  • UBS O'Connor first reported a position in SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q4 2023 and held it in 4 quarters.
  • UBS O'Connor's SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $13.2K in Q2 2024.
  • 1 fund tracked by Wall St. Rank held SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.